TG

Tejasvi Ghanshala

Active Director Director DIN 11853318
DIN 11853318 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Tejasvi Ghanshala

Data last updated:

Tejasvi Ghanshala is a Director at Graphic Era Medicare Private Limited (since 2026) and Director at Graphic Era Meditech Private Limited (since 2026).

DIN 11853318
Primary Designation Director
First Appointment 03 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Graphic Era Medicare Private Limited U86100HR2026PTC150305
Director10 Sep 20262026Active
Graphic Era Meditech Private Limited U86100DL2026PTC469212
Director03 Aug 20262026Active

Directorship timeline

Open interactive timeline →
Graphic Era Meditech Private Limited
Graphic Era Medicare Private Limited
Premium access

Shareholding and investment profile for Tejasvi Ghanshala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tejasvi Ghanshala

Tejasvi Ghanshala currently holds 2 directorships: Graphic Era Medicare Private Limited (Director, since 10 Sep 2026); Graphic Era Meditech Private Limited (Director, since 03 Aug 2026).

Tejasvi Ghanshala was first appointed on 03 Aug 2026 as Director at Graphic Era Meditech Private Limited.

The current boards of Tejasvi Ghanshala's companies include Kamal Kumar Ghanshala (Graphic Era Medicare Private Limited), Rakhi Ghanshala (Graphic Era Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available